-
Notifications
You must be signed in to change notification settings - Fork 14
Home
Julien Guérin edited this page Jan 26, 2021
·
15 revisions
| Property | Definition EN |
|---|---|
| Id | Patient ID in the center providing the information |
| Gender | Gender of the patient |
| Ethnicity | Ethnicity of the patient |
| BirthDate | Date of birth of the patient |
| DeathDate | Date of death of the patient |
| ProviderCenterId | Center ID of the center providing the information |
| OriginCenterId | Center ID of the center of origin of the patient |
| CauseOfDeath | Description of the cause of death of the patient |
| LastNewsDate | Date of last news (= date of last patient visit if there is no other information available) (day is set to the 15th) |
| LastNewsStatus | Indicator of the patient's last known vital status (alive or deceased) |
| Property | Definition EN |
|---|---|
| Date | Date of consent signature |
| GeneticAnalysisAuthorization | Consent for genetic analysis |
| Property | Definition EN |
|---|---|
| PathologyCode | International code for the related disease (other than cancer). 3 characters. |
| DiagnosisDate | Date of diagnosis for the related disease. |
| PathologyEndDate | Date of the end of the related disease (if occuring and known) |
| Property | Definition EN |
|---|---|
| TopographyCode | International code for the localization of the oncologic primary site |
| Parentage | Family relationship |
| Property | Definition EN |
|---|---|
| Type | The field 'Type' allows to describe the 'Cancer' event as a global disease, as well as the various events constituting this disease (primary tumor, local relapse, metastatic relapse...) |
| StartDate | Date of start of cancer event or disease |
| EndDate | Date of end of cancer event or disease |
| PerformanceStatus | Definition of the autonomy scale (Karnofsky scale or OMS) |
| G8 | Tool for the evaluation of the general condition of the patient |
| HistologicalGradeType | List of histological grading scales |
| HistologicalGradeValue | Value of histological grade |
| StadeType | List of stage scales |
| StadeValue | Stage value |
| DiagnosisDate | Date of diagnosis of the tumor event |
| TopographyCode | Localisation of the primary tumor |
| MorphologyCode | International code of lesion / histological type / tumor morphology of the tumoral event |
| Laterality | Laterality of location (if it exists) |
| Property | Definition EN |
|---|---|
| T | Size of the tumor, propagation the site of the primary tumor |
| N | Propagation at the ganglion level |
| M | Remote propagation, presence of metastases |
| Version | TNM classification version |
| Type | c, p, r,... |
| Property | Definition EN |
|---|---|
| Code | Code of analysis |
| Type | Type of analysis |
| Date | Date of analysis |
| Property | Definition EN |
|---|---|
| Date | Date of assessment of treatment response |
| Status | Assessment of treatment response |
| Property | Definition EN |
|---|---|
| Code | Biomarker name |
| Value | Biomarker value |
| Unit | Biomarker unit |
| Property | Definition EN |
|---|---|
| Type | Type of treatment |
| LineNumber | Line of treatment |
| ActivityCode | CCAM code of the medical act |
| StartDate | Date of treatment start |
| EndDate | Date of treatment end |
| ClinicalTrialContext | Treatment performed in a clinical study setting |
| ClinicalTrialName | Name of the clinical study |
| ClinicalTrialId | NCT identifier of the clinical study |
| SurgeryResectionQuality | Quality of resection (anapath) |
| SurgeryNature | Nature of the surgery |
| Property | Definition EN |
|---|---|
| Code | International code of the adverse event occurring during treatment (excluding other cancer), only the first 4 letters. |
| Date | Date of the diagnosis of the adverse event |
| EndDate | End date of the adverse event (if known) |
| Grade | Grade of the adverse event |
| Property | Definition EN |
|---|---|
| Code | Therapeutic classification code (5th level if possible) |
| Name | Name of the molecule |
| Property | Definition EN |
|---|---|
| ExternalAccession | Unique identifier of the sample |
| ParentExternalAccession | Unique identifier of the parent sample (if there is one, example histo#) |
| CollectDate | Date of sampling |
| TopographyCode | Code of tumor localization |
| Nature | Nature of the sample |
| Origin | Nature of the original sample (Healthy or Tumoral) |
| StorageTemperature | Mode of preservation |
| TumorCellularity | Percentage of tumor cells quantified in the sample |
| Property | Definition EN |
|---|---|
| TechnicalProtocol | Protocol used for the experiment |
| PlatformName | Technological platform name (provider followed by the platform name) |
| PlatformAccession | GEO Identifier of the platform |
| DateOfExperiment | Date when the experiment was performed |
| Property | Definition EN |
|---|---|
| Name | Name of the panel targeted by the experimental analysis (provider followed by the panel name) |
| Property | Definition EN |
|---|---|
| AnalyticPipelineCode | Identifier of the pipeline used into the analysis (unique in the center) |
| Property | Definition EN |
|---|---|
| AlgorithmicCellularity | Calculated percentage of tumor cells in sample |
| AlgorithmicPloidy | Calculated number of sets of chromosomes in a cell of the sample |
| NumberOfBreakPoints | Calculated number of break points in genomic profile |
| Property | Definition EN |
|---|---|
| AlterationType | General type of the detected genetic alteration (high level type) |
| Pathogenicity | Conclusion of the biologist on the pathogenicity of the variant before the Molecular Tumor Board |
| Actionability | Conclusion of the clinicians wether the variant is actionable or not during the Molecular Tumor Board |
| ProposedForOrientation | Is the ClinicalTumorBoardConclusion used to orient the treatment decision ? |
| Property | Definition EN |
|---|---|
| Type | Type of validation of the detected alteration |
| Method | Validation method depending on the type of validation |
| Status | Validation status of the detected alteration |
| Property | Definition EN |
|---|---|
| Chromosome | Chromosome containing the genetic finding |
| GenomicStart | Nucleotide location for start of genomic finding on the positive (+) genomics strand, 1-based |
| GenomicStop | Nucleotide location for end of genomic finding on the positive (+) genomic strand, 1-based |
| GenomeBuild | Genome Build used for reference |
| Cytoband | Cytogenetic location |
| Property | Definition EN |
|---|---|
| Type | Type of the genome entity. For eg: gene, mRNA, ncRNA... |
| Database | Database of the genome entity |
| Id | Identifier of the genome entity in the genome entity database |
| Symbol | Hugo gene symbol |
| Property | Definition EN |
|---|---|
| Type | Type of the fusion event. For eg: translocation, readthrough |
| Point5prime | Position of the fusion point on the 5 prime partner |
| Chromosome5prime | |
| Point3prime | Position of the fusion point on the 3 prime partner |
| Chromosome3prime | |
| InFrame | Specify whether the fusion is in frame |
| NbSpanningPair | Number of reads pairs spanning the fusion |
| NbSplitReads | Number of reads containing the fusion point |
| Property | Definition EN |
|---|---|
| SegmentIntensity | Intensity of the measured signal |
| SegmentGenomicStatus | Copy number status |
| CopyNumber | Estimated DNA copy number |
| LOH | Is the segment located in a region of loss of heterozygosity ? (can be independant from copy number information |
| SegmentSize |
| Property | Definition EN |
|---|---|
| ReferenceAllele | Plus strand reference allele at this position. Include the sequence deleted for a deletion, or '-' for an insertion. |
| AlternativeAllele | Plus strand observed alternative allele at this position. Include the sequence inserted for a insertion, or '-' for a deletion. |
| DNASequenceVariationType | Codified type of the DNA sequence variation |
| Property | Definition EN |
|---|---|
| ReferenceType | |
| ReferenceDatabase | |
| ReferenceValue | |
| MutationPredictionAlgorithm | Algorithm to predict the variation effect over the protein |
| MutationPredictionValue | Prediction of the variation effect over the protein |
| MutationPredictionScore | Level of confidence of the prediction of the variation effect over the protein |
| PfamDomain | Pfams domains related to alteration position |
| PfamId | Identifier of Pfams domains related to alteration position |
| DNARegionName | Human readable name for the region of interest related to the transcript (eg: exon1, intron1, UTR3') |
| DNASequenceVariation | HGVS nomenclature on the chosen transcript |
| AminoAcidChange | HGVS nomenclature on the chosen protein transcript |
| GenomicSequenceVariation | HGVS nomenclature on the given GenomeReferenceSequenceId. |
| RNASequenceVariation | HGVS nomenclature on the given TranscriptReferenceSequenceId and experimentely observed on RNA. |
| AminoAcidChangeType | nomenclature of changes at protein-level |
| FusionPrimeEnd | Prime end of the fusion partner |
| Strand | Strand |
| OnSplicingSite | Indicate wether the variant is on a splicing site |
| Property | Definition EN |
|---|---|
| PositionReadDepth | Total sequencing depth at the variant position observed in the specimen |
| VariantReadDepth | Sequencing depth of the alternative allele at the variant position observed in the specimen |
| StrandBias | Indication of the existence of strand bias at the variant position |
| GenomicSourceClass | Genomic class of the variant (eg: germline, somatic, and prenatal) |
| AllelicState | Level of allelic occurrence of a DNA Sequence Variation |
| Property | Definition EN |
|---|---|
| DataType | Type of the expression value corresponding to the level of data processing |
| Value | Numerical value for expression |
- Patient
- Consent
- RelatedPathology
- FamilyCancerHistory
- TumorPathologyEvent
- TNM
- Analysis
- ResponseEvaluation
- Biomarker
- Treatment
- AdverseEvent
- Drug
- BiologicalSample
- Technology
- Panel
- AnalysisProcess
- OmicAnalysis
- AlterationOnSample
- Validation
- Alteration
- GenomeEntity
- Fusion
- CNV
- Variant
- Annotation
- VariantInSample
- GeneExpression